84049-34-3

Basic information

• Product Name: racemic cis-1-benzyloxy-7-oxabicyclo[4.1.0]heptane
• CAS NO: 84049-34-3
• Molecular Weight: 204.269
• Mol File: 84049-34-3.mol

Chemical Properties

• CAS DataBase Reference: racemic cis-1-benzyloxy-7-oxabicyclo[4.1.0]heptane(CAS DataBase Reference)
• NIST Chemistry Reference: racemic cis-1-benzyloxy-7-oxabicyclo[4.1.0]heptane(84049-34-3)
• EPA Substance Registry System: racemic cis-1-benzyloxy-7-oxabicyclo[4.1.0]heptane(84049-34-3)

Safety Data

• Hazardous Substances Data: 84049-34-3(Hazardous Substances Data)

Upstream product

• 32700-48-4 [(cyclohex-2-en-1-yloxy)methyl]benzene 
• 100-39-0 benzyl bromide 
• 1192-78-5 (1R*,2R*,3S*)-2,3-epoxycyclohexanol 
• 822-67-3 Cyclohex-2-enol 
• 1192-78-5 2,3-epoxycyclohexanol 
• 126059-76-5 (1RS,2RS,6SR)-7-oxabicyclo[4.1.0]heptan-2-ol 

Relevant articles and documents

A 3,4-Epoxypiperidine structure as a novel and simple DNA-cleavage unit

Based on the 4-hydroxy-1-azabicyclo[3.1.0]hexane structure of azinomycin, a 3,4-epoxypiperidine structure was designed as a novel and simple alkylating molecular unit, and some 3,4-epoxypiperidine derivatives were found to show DNA-cleavage activity, the structural requirements for which were revealed.

INHIBITORS OF INFLUENZA VIRUSES REPLICATION

PROBLEM TO BE SOLVED: To provide inhibitors of influenza virus replication. SOLUTION: Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient comprise administering to the biological sample or patient an effective amount of a compound represented by structural formula (I) or a pharmaceutically acceptable salt thereof, where the values of structural formula (IA) are as described herein. A compound is represented by structural formula (IA) or a pharmaceutically acceptable salt thereof, where the values of structural formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle. COPYRIGHT: (C)2015,JPO&INPIT

Synthesis of functionalized octahydroindoles related to daphnyphyllum alkaloids

Functionalized octahydroindoles were synthesized from (±)-cyclohex- 2-en-1-ol as potential intermediates for convergent syntheses of several alkaloids from plants of the Daphnyphyllum genus. Georg Thieme Verlag Stuttgart, New York.

Cycloalkane Derivatives

Disclosed herein are therapeutic agents and/or preventive agents for pain or therapeutic agents and/or preventive agents for a sodium channel associated disease. The present invention provides compounds represented by the following formula (I) or pharmacologically acceptable salts thereof:

SELECTIVE KINASE INHIBITORS

Provided are pyrimidine compounds for inhibiting of Syk kinase, intermediates used in making such compounds, methods for their preparation, pharmaceutical compositions thereof, methods for inhibition Syk kinase activity, and methods for treating conditions mediated at least in part by Syk kinase activity.

Synthesis of hexahydro-1H-benzo[c]chromen-1-amines via the intramolecular ring-opening reactions of aziridines by π-nucleophiles

The intramolecular cyclization of aziridines with π-nucleophiles can be a useful route to a number of heterocyclic and carbocyclic systems. This methodology has been applied to the synthesis of hexahydro-1H-benzo[c]chromen-1- amines, the basic skeleton of many amaryllidaceae alkaloids. The success of the aziridine cyclization is largely dependent on the N-substitution of aziridine, with activated aziridines not undergoing the cyclization reaction. Only N-H-, N-alkyl- and N-arylaziridines underwent the cyclization reaction. The ring opening of an unactivated aziridines with a π-nucleophile is one of the first examples of such a reaction. Georg Thieme Verlag Stuttgart.

A hydrogen-bonded model of the Syn epoxidation of cyclic allylic ethers under Payne conditions

The syn selectivity observed for the Payne (PhCN/H2O2) epoxidation of cyclohexenyl ethers is consistent with an hydrogen-bonded model implying the allylic ether oxygen and the imino hydrogen of the in situ generated perbenzimidic acid. The geometry of the two most stable conformers, deduced from AM1 calculations. allows both hydrogen bonding and oxygen transfer.

Regiochemical control of the ring opening of 1,2-epoxides by means of chelating processes. 8. Synthesis and ring opening reactions of cis- and trans-oxides derived from 3-benzyloxycyclohexene and 2-benzyloxy-5,6-dihydro-2H-pyran

The regiochemical outcome of the ring opening of 1,2-epoxides bearing polar remote functionalization through chelation processes assisted by metal ions, was verified in cyclic oxirane systems having the polar functionality in an allylic position to the oxirane ring. The diastereoisomeric cis/trans epoxide pairs 5,6 and 7,8 derived from 3-benzyloxycyclohexene, and 2-benzyloxy-5,6-dihydro-2H-pyran, respectively, were prepared and several of their opening reactions were studied. The regioselectivity observed largely depends on the reaction conditions (standard or metal-assisted) and, interestingly, on the nature of the nucleophile used.

SYN-STEREOSELECTIVE EPOXIDATION OF ALLYLIC ETHERS USING CF3CO3H

Good syn-stereoselectivity is observed in the epoxidation of allylic ethers with CF3CO3H, indicating a new type of hydrogen-bonded transition state.